Noninvasive Biocompatible Injectable, developed by Merz Aesthetics, is a biocompatible and noninvasive injectable filler. It consists of approximately 30% Calcium Hydroxylapatite (CaHA) microspheres suspended in an aqueous gel carrier made of 70% carboxymethylcellulose. Noninvasive Biocompatible Injectable is versatile and is effective in providing a triple effect of contouring, collagen stimulation, and face lifting.
Our skin is primarily composed of the extracellular matrix (ECM). It maintains our skin’s structure, health, and elasticity. The four main components of the ECM include:
Another key component is fibroblasts. These cells produce elastin, collagen, and other ECM elements, thus essential in maintaining our skin’s integrity and helping in wound healing.
Understanding these components and their functions sheds light on how Noninvasive Biocompatible Injectable can effectively rejuvenate the skin.
As we age, our skin undergoes several changes that contribute to a decline in its youthful appearance. Collagen and elastin production diminishes, leading to a weaker extracellular matrix and reduced moisture retention. Additionally, fibroblasts, the cells responsible for tissue repair, become less effective and may even enter a state of senescence, releasing inflammatory factors that further accelerate skin ageing.
Noninvasive Biocompatible Injectable is a comprehensive solution to these age-related skin changes. The CaHA microspheres help to stimulate the body’s natural production of collagen, improving skin elasticity and providing long-term structural support. The Carboxymethylcellulose (CMC) gel carrier delivers immediate volume to targeted areas, addressing wrinkles and folds.
Noninvasive Biocompatible Injectable is the original collagen biostimulator with over 20 years of clinical experience, more than 250 published studies, and 15 million treatments performed globally.
In 2003, Noninvasive Biocompatible Injectable received CE Certification, the standard for product safety in the European Union. Subsequently, the FDA approved it in 2006, marking its entry into the American market. Most notably, Noninvasive Biocompatible Injectable became the first facial filler to gain FDA approval for hand augmentation. With over 250 publications supporting its efficacy, Noninvasive Biocompatible Injectable is recognised for its safety and effectiveness in aesthetic treatments.
Noninvasive Biocompatible Injectable can effectively treat:
Dr Hoe Ying Min is dedicated to ensuring a comfortable experience for all her patients. Upon arrival, Dr Hoe will conduct a thorough consultation, which includes understanding your medical history to ensure that you are a suitable candidate for Noninvasive Biocompatible Injectable.
Next, a personalised treatment plan will be curated; this includes financial counselling, photo-taking, and consent-taking. When your treatment begins, your skin will be cleansed, and a topical anaesthetic will be applied. Noninvasive Biocompatible Injectable is then carefully injected into the treatment area.
After the treatment, you can expect immediate volume restoration and smoothing of wrinkles. Your skin will continue to improve as collagen production increases post-treatment post-treatment. Individual results may vary, but most clients will experience a youthful and refreshed appearance.
Mild redness and swelling may appear for one to two days following treatment; however, you can resume normal activities and apply makeup the very next day.
Results are visible right away, with full effects becoming apparent within one to two months as new collagen develops. The results typically last 12 to 18 months, and annual touch-ups are recommended to maintain optimal outcomes.
Noninvasive Biocompatible Injectable's side effects are infrequent, and numerous clinical studies confirm its safety. However, some common adverse effects may include bruising, discomfort, and swelling. Rarely, more serious complications can arise, such as the formation of nodules or granulomas, infections, vascular occlusion, and allergic reactions.
Juvederm, Restylane, and Belotero are popular hyaluronic acid (HA) dermal fillers that restore volume and smooth the skin. These fillers are ideal for areas with thinner skin, such as the lips and undereye region.
While HA fillers offer temporary results,Noninvasive Biocompatible Injectable provides a more long-lasting solution. Noninvasive Biocompatible Injectable not only restores volume but also stimulates collagen production, improving skin texture and elasticity. This makes it a preferred choice for clients seeking sustained rejuvenation.
Noninvasive Biocompatible Injectable, PLLA Collagen Stimulator, and PCL Collagen Stimulator are collagen biostimulators with long track records and good clinical outcomes. This blog post details their various merits.
